Status:

COMPLETED

Feasibility Study for Provoked Vestibulodynia

Lead Sponsor:

Université de Sherbrooke

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Conditions:

Vestibulodynia

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

The feasibility and acceptability of a somatosensory rehabilitation program and an educational pain management program will be investigated in women with provoked vestibulodynia. Forty-four women will...

Eligibility Criteria

Inclusion

  • Diagnosis of provoked vestibulodynia according to a standardized gynaecologic exam
  • Moderate to severe pain (≥5/10) located in the vulvar vestibule for at least 90% of vaginal penetrations or attempted vaginal penetrations or activities with pressure on the vagina for at least 3 months

Exclusion

  • Other causes of vulvo-vaginal pain (e.g. spontaneous vulvovaginal pain not related to sexual intercourse/contact, dermatological condition, herpes, vulvo-vaginal atrophy)
  • Prior vulvo-vaginal surgery or radiotherapy
  • Post-menopausal status
  • Participant refusal to not use other treatments for the provoked vestibulodynia during the entire study (until 3 months post-treatment);
  • Other urogynecological condition (e.g. pelvic organs prolapse ≥3, current urinary/vaginal infection or in the last 3 months)
  • Prior use of Somatosensory Rehabilitation Program or Educational Pain Management Program
  • Current or past pregnancy in the last year;
  • Changes of medication that could influence pain perception (e.g. analgesic, antidepressant) in the last 3 months
  • Major psychological condition (e.g. depressive symptoms, anxiety) which can present a security issue for the participant
  • Other medical conditions that could interfere with the study

Key Trial Info

Start Date :

May 16 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2023

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT05342402

Start Date

May 16 2022

End Date

July 31 2023

Last Update

September 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre Hospitalier Universitaire de Sherbrooke

Sherbrooke, Quebec, Canada, J1H 5N4